Performance Measures
Performance measures are a vital component of health care quality. They serve as a mechanism to evaluate quality and cost-of-care performance. They drive improvement, allow patients to make informed decisions and influence provider payment. Measures can also objectively assess how well and appropriately health care is delivered compared to recognized standards.
Call for Input on New Breast Imaging Measures
Mammography quality and cost measures are being finalized before CMS鈥 consideration for future inclusion in the Merit-based Incentive Payment System (MIPS). The 黑料网 needs your input now and will solicit your comments as the quality measures progress through development and the rule-making process.
ACR-Sponsored Measures Under Development
Vetted by the 黑料网 Measurement Strategy Group, measure concepts meeting the criteria for high priority are entered into the 黑料网 Metrics Committee measure development pipeline. As the standing committee charged with 黑料网 measure development, Metrics Committee members serve with invited stakeholders to develop measures in their pipeline more fully.
黑料网 is always seeking new concepts for measure development; please use this form to submit ideas for measures you'd like to see developed.
If you are interested in testing any of the new measures currently under development by 黑料网 at your facility, please provide your contact information using our .
Diagnostic Imaging 2018 Quality Measures
Detailed Measure List
These measures were finalized in May 2018.
- Measure 1: Use of Structured Reporting in Prostate MRI
- Measure 2: Follow-up Recommendations for Incidental Findings of Simple-Appearing Cystic Renal Masses
- Measure 3: Surveillance Imaging for Liver Nodules < 10 mm in Patients at Risk for Hepatocellular Carcinoma (HCC)
- Measure 4: Use of Quantitative Criteria for Oncologic FDG PET Imaging
- Measure 5: Use of Low Dose Cranial CT or MRI Examinations for Patients with Ventricular Shunts
- Measure 6: Use of Low Dose CT Studies for Adults with Suspicion of Urolithiasis or Nephrolithiasis
If your radiology practice would like to help test these measures, please fill out a or email Measure.Development@acr.org.
Diagnostic Imaging 2017 Quality Measures
Detailed Measure List
- Measure 1: Recommended Follow-up for Imaging Findings
- Measure 2: Appropriateness: Follow-up Computed Tomography (CT) Imaging for Incidentally-Detected Pulmonary Nodules According to Recommended Guidelines
- Measure 3: Appropriate Follow-up Imaging for Benign Adrenal Masses
- Measure 4: Interpretation of CT Pulmonary Angiography (CTPA) for Pulmonary Embolism (PE)
- Measure 5: Incidental Coronary Artery Calcification Reported on Chest CT
The 黑料网 is looking for radiology practices to help us test and validate this set of quality reporting measures. To volunteer, please fill out a or email Measure.Development@acr.org.